Does MOLSIDOMINE Cause Off label use? 24 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Off label use have been filed in association with MOLSIDOMINE. This represents 6.3% of all adverse event reports for MOLSIDOMINE.
24
Reports of Off label use with MOLSIDOMINE
6.3%
of all MOLSIDOMINE reports
13
Deaths
13
Hospitalizations
How Dangerous Is Off label use From MOLSIDOMINE?
Of the 24 reports, 13 (54.2%) resulted in death, 13 (54.2%) required hospitalization, and 16 (66.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which MOLSIDOMINE Alternatives Have Lower Off label use Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL